circCDYL介导细胞自噬影响卵巢癌细胞增殖及凋亡
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

海南省卫生健康行业科研项目(22A200112)


Effects of circCDYL mediated autophagy on the proliferation and apoptosis of ovarian cancer cells
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探究circCDYL对卵巢癌细胞增殖和凋亡的影响及机制。方法 卵巢癌细胞OC3细胞分为Vector组(转染空载质粒)、circCDYL组(转染circCDYL质粒)、circCDYL+CHQ组(转染circCDYL质粒后与10 μmol/L 氯喹孵育)和circCDYL+miR-185-5p mimic组(共转染circCDYL质粒和miR-185-5p mimic);SK-OV-3细胞分为sh-NC组(转染shRNA 阴性对照)、sh-circCDYL组(转染circCDYL shRNA)、sh-circCDYL+Rapa组(转染circCDYL shRNA后与1 μmol/L 雷帕霉素孵育)和sh-circCDYL+miR-185-5p inhibitor组(共转染circCDYL shRNA和miR-185-5p inhibitor);CCK8和克隆形成实验检测细胞增殖,流式细胞术检测细胞凋亡,蛋白免疫印迹(Western Blot)检测各组细胞LC3-Ⅱ和p62蛋白表达,双荧光素酶报告基因实验验证circCDYL和miR-185-5p的靶向关系。结果 circCDYL组OC3细胞增殖能力和LC3-Ⅱ蛋白表达高于Vector组(P<0.05),细胞凋亡显著和p62蛋白表达低于Vector组(P<0.05)。circCDYL+CHQ组OC3细胞增殖能力低于circCDYL组(P<0.05),细胞凋亡高于circCDYL组(P<0.05)。sh-circCDYL组SK-OV-3增殖能力和LC3-Ⅱ蛋白表达低于sh-NC组(P<0.05),细胞凋亡和p62蛋白表达高于sh-NC组(P<0.05)。sh-circCDYL+Rapa组SK-OV-3细胞增殖能力高于sh-circCDYL组(P<0.05),细胞凋亡低于sh-circCDYL组(P<0.05)。circCDYL+miR-185-5p mimic组OC3细胞LC3-Ⅱ蛋白表达低于circCDYL组(P<0.05),p62蛋白表达高于circCDYL组(P<0.05)。sh-circCDYL+miR-185-5p inhibitor组SK-OV-3细胞LC3-Ⅱ蛋白表达高于sh-circCDYL组(P<0.05),p62蛋白表达低于sh-circCDYL组(P<0.05)。结论 circCDYL可通过调控自噬影响卵巢癌细胞的增殖和凋亡

    Abstract:

    Objective To investigate the effects and mechanisms of circCDYL on the proliferation and apoptosis of ovarian cancer cells. Methods Cervical cancer cell OC3 were divided into Vector group (transfected with empty plasmids), circCDYL group (transfected with circCDYL plasmids), circCDYL+CHQ group (transfected with circCDYL plasmids and incubated with 10μmol/L chloroquine) and circCDYL+miR-185-5p mimic group (co-transfected with circCDYL plasmids and miR-185-5p mimic). SK-OV-3 cells were divided into sh-NC group (transfected with shRNA negative control), sh-circCDYL group (transfected with circCDYL shRNA), sh-circCDYL+Rapa group (transfected with circCDYL shRNA and incubated with 1μmol/L rapamycin) and sh-circCDYL+miR-181b-5p inhibitor group (co-transfected with circCDYL shRNA and miR-181b-5p inhibitor). Apoptosis was detected by flow cytometry. The ability of proliferation could be valued by CCK8 and clone formation. Western blot detected LC3-Ⅱ and p62 proteins expression. The targeting relationship between circCDYL and miR-185-5p was verified by dual luciferase reporter genes. Results The proliferation ability and LC3-Ⅱ protein expression of OC3 cells in the circCDYL group were higher than those in the Vector group (P<0.05), while cell apoptosis and p62 expression were lower than those in the Vector group (P<0.05). The proliferation ability of OC3 cells in the circCDYL+CHQ group was lower than that in the circCDYL group (P<0.05), and cell apoptosis was higher than that in the circCDYL group (P<0.05). The proliferation ability and LC3-Ⅱ protein expression of SK-OV-3 in the sh-circCDYL group were lower than those in the sh-NC group (P<0.05), while cell apoptosis and p62 expression were higher than those in the sh-NC group (P<0.05). The proliferation ability of SK-OV-3 cells in the sh-circCDYL+Rapa group was higher than that in the sh-circCDYL group (P<0.05), and the apoptosis was lower than that in the sh-circCDYL group (P<0.05). The LC3-Ⅱ expression of OC3 cells in the circCDYL+miR-185-5p mimic group was lower than that in circCDYL group (P<0.05), and the p62 protein expression was higher than that in circCDYL group (P<0.05). The expression of LC3-Ⅱ protein of SK-OV-3 cells in the sh-circCDYL+miR-185-5p inhibitor group was higher than that in the sh-circCDYL group (P<0.05), and the expression of p62 protein was lower than that in the sh-circCDYL group (P<0.05). Conclusion circCDYL affects the proliferation and apoptosis of ovarian cancer cells by regulating autophagy

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-05-19
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司